Aurélia Huyghe

Dr. Aurélia Huyghe


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2023 in Trends in Cell Biology
Verified
Journal Article
Open access
AHAurélia Huyghe
Aurélia Huyghe
ATAneta Trajkova
Aneta Trajkova
FLFabrice Lavial
Fabrice Lavial
The multistep process of in vivo reprogramming, mediated by the transcription factors (TFs) Oct4, Sox2, Klf4, and c-Myc (OSKM), holds great promise for the development of rejuvenating and regenerative strategies. However, most of the approaches developed so far are accompanied by a persistent risk of tumorigenicity. Here, we review the groundbreaking effects of in vivo reprogramming with a particular focus on rejuvenation and regeneration. We discuss how the activity of pioneer TFs generates cellular plasticity that may be critical for inducing not only reprogramming and regeneration, but also cancer initiation. Finally, we highlight how a better understanding of the uncoupled control of cellular identity, plasticity, and aging during reprogramming might pave the way to the development of rejuvenating/regenerating strategies in a nontumorigenic manner.

8 September 2022 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
AHAurélia Huyghe
Aurélia Huyghe
GFG. Furlan
G. Furlan
JSJ. Schroeder
J. Schroeder
ECE. Cascales
E. Cascales
ATA. Trajkova
A. Trajkova
FLF. Lavial
F. Lavial
Coordinated changes of cellular plasticity and identity are critical for pluripotent reprogramming and oncogenic transformation. However, the sequences of events that orchestrate these intermingled modifications have never been comparatively dissected. Here, we deconvolute the cellular trajectories of reprogramming (via Oct4/Sox2/Klf4/c-Myc) and transformation (via Ras/c-Myc) at the single-cell resolution and reveal how the two processes intersect before they bifurcate. This approach led us to identify the transcription factor Bcl11b as a broad-range regulator of cell fate changes, as well as a pertinent marker to capture early cellular intermediates that emerge simultaneously during reprogramming and transformation. Multiomics characterization of these intermediates unveiled a c-Myc/Atoh8/Sfrp1 regulatory axis that constrains reprogramming, transformation and transdifferentiation. Mechanistically, we found that Atoh8 restrains cellular plasticity, independent of cellular identity, by binding a specific enhancer network. This study provides insights into the partitioned control of cellular plasticity and identity for both regenerative and cancer biology.

5 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
GFGiacomo Furlan
Giacomo Furlan
AHAurélia Huyghe
Aurélia Huyghe
NCNoémie Combémorel
Noémie Combémorel
FLFabrice Lavial
Fabrice Lavial
A challenge during development is to ensure lineage segregation while preserving plasticity. Using pluripotency progression as a paradigm, we review how developmental transitions are coordinated by redeployments, rather than global resettings, of cellular components. We highlight how changes in response to extrinsic cues (FGF, WNT, Activin/Nodal, Netrin-1), context- and stoichiometry-dependent action of transcription factors (Oct4, Nanog) and reconfigurations of epigenetic regulators (enhancers, promoters, TrxG, PRC) may confer robustness to naïve to primed pluripotency transition. We propose the notion of Molecular Versatility to regroup mechanisms by which molecules are repurposed to exert different, sometimes opposite, functions in close stem cell configurations.

23 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SDSébastien Durand
Sébastien Durand
MBMarion Bruelle
Marion Bruelle
FBFleur Bourdelais
Fleur Bourdelais
BBBigitha Bennychen
Bigitha Bennychen
JBJuliana Blin-Gonthier
Juliana Blin-Gonthier
MGMathieu GABUT
Mathieu GABUT
Embryonic stem cell (ESC) fate decisions are regulated by a complex circuitry that coordinates gene expression at multiple levels from chromatin to mRNA processing. Recently, ribosome biogenesis and translation have emerged as key pathways that efficiently control stem cell homeostasis, yet the underlying molecular mechanisms remain largely unknown. Here, we identified RSL24D1 as highly expressed in both mouse and human pluripotent stem cells. RSL24D1 is associated with nuclear pre-ribosomes and is required for the biogenesis of 60S subunits in mouse ESCs. Interestingly, RSL24D1 depletion significantly impairs global translation, particularly of key pluripotency factors and of components from the Polycomb Repressive Complex 2 (PRC2). While having a moderate impact on differentiation, RSL24D1 depletion significantly alters ESC self-renewal and lineage commitment choices. Altogether, these results demonstrate that RSL24D1-dependant ribosome biogenesis is both required to sustain the expression of pluripotent transcriptional programs and to silence PRC2-regulated developmental programs, which concertedly dictate ESC homeostasis.

25 August 2023 in Cells
Verified
Journal Article
Open access
PDF file
MVMona Veithen
Mona Veithen
AHAurélia Huyghe
Aurélia Huyghe
PAPriscilla Van Den Ackerveken
Priscilla Van Den Ackerveken
SFSo-ichiro Fukada
So-ichiro Fukada
HKHiroki Kokubo
Hiroki Kokubo
brigitte malgrangebrigitte malgrange
brigitte malgrange
It is widely accepted that cell fate determination in the cochlea is tightly controlled by different transcription factors (TFs) that remain to be fully defined. Here, we show that Sox9, initially expressed in the entire sensory epithelium of the cochlea, progressively disappears from differentiating hair cells (HCs) and is finally restricted to supporting cells (SCs). By performing ex vivo electroporation of E13.5–E14.5 cochleae, we demonstrate that maintenance of Sox9 expression in the progenitors committed to HC fate blocks their differentiation, even if co-expressed with Atoh1, a transcription factor necessary and sufficient to form HC. Sox9 inhibits Atoh1 transcriptional activity by upregulating Hey1 and HeyL antagonists, and genetic ablation of these genes induces extra HCs along the cochlea. Although Sox9 suppression from sensory progenitors ex vivo leads to a modest increase in the number of HCs, it is not sufficient in vivo to induce supernumerary HC production in an inducible Sox9 knockout model. Taken together, these data show that Sox9 is downregulated from nascent HCs to allow the unfolding of their differentiation program. This may be critical for future strategies to promote fully mature HC formation in regeneration approaches.

30 March 2026
Verified
Thesis
Closed access
AHAurélia Huyghe
Aurélia Huyghe
Les eIF2B-pathies représentent un groupe de leucodystrophies de transmission autosomique récessive du à des mutations du facteur ubiquitaire eIF2B. Celui-ci intervient dans l’initiation de la traduction et ses régulations, particulièrement en cas de stress cellulaires, grâce à son activité d’échange de guanine (GEF). Un large spectre clinique et mutationnel a été décrit pour cette pathologie.La diminution de l’activité GEF a pu être validée comme marqueur diagnostique spécifique des eIF2B-pathies dans les lymphoblastes de patients atteints avec un seuil d’activité à 77,5% pour une spécificité de 100% et une sensibilité de 89%.La compréhension des mécanismes moléculaires en cause a ensuite été recherchée selon trois approches :- une première focalisée sur l’étude de la réponse au stress du réticulum endoplasmique (RE) dans les lymphoblastes de patients eIF2B-mutés. L’hyper-activation transcriptionnelle et traductionnelle des gènes de la réponse au stress du RE, observée dans d’autres études et sur d’autres types cellulaires n’a pas été retrouvée dans cette étude.- une approche globale d’étude transcriptomique différentielle dans des fibroblastes primaires de patients eIF2B-mutés soumis ou non à un stress cellulaire. La comparaison du transcriptome avec celui de contrôles sains et de patients porteurs d’une autre leucodystrophie n’a pas permis de mettre en évidence un effet spécifique du stress dans les fibroblastes eIF2B-mutés. En revanche, il a pu être montré une dérégulation de l’expression de 70 gènes spécifiquement dans ces fibroblastes ainsi que l’implication de voies métaboliques telles que l’épissage et la stabilité des ARNm, importantes au cours du développement du système nerveux central. Ces gènes trouvés dérégulés dans les fibroblastes, appartenant notamment à la famille des hnRNP, ont été ensuite validés dans les cerveaux de patients eIF2B-mutés et une anomalie d’épissage de certains transcrits importants pour les cellules gliales a également été identifiée.- enfin, pour valider l’hypothèse d’une anomalie développementale des cellules gliales, le modèle des cellules souches embryonnaires (ESC) a été utilisé et un défaut génétique a été introduit dans ces cellules afin de mimer les mutations eIF2B. Une anomalie de différentiation de ces ESC en cellules gliales a pu être mise en évidence dans ce modèle qui pourrait alors constituer un outil de choix pour tester des molécules pouvant potentiellement améliorer la différenciation de ces cellules, principales en cause dans cette pathologie.